- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.01. | Hypha Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.01. | Hypha Labs, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 30.12.25 | Hypha Labs, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 01.10.25 | Hypha Labs, Tryptomics enter phase II of mushroom tech partnership | 1 | Investing.com | ||
| 01.10.25 | Hypha Labs, Inc.: Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator with World-Class Internal Quality Control & Fungal Genomics | 491 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, today announced the official... ► Artikel lesen | |
| 29.09.25 | Hypha Labs to build commercial-scale mushroom accelerator | 1 | Investing.com | ||
| HYPHA LABS Aktie jetzt für 0€ handeln | |||||
| 29.09.25 | Hypha Labs, Inc.: Hypha Labs and Automated Technical Services Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing | 266 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / September 29, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it... ► Artikel lesen | |
| 11.08.25 | Hypha Labs, Inc.: Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator | 269 | ACCESS Newswire | Simple, In-Home Eight Day Cycle Generates Significant Yields of The World's Most Popular Mushroom Strains LAS VEGAS, NV / ACCESS Newswire / August 11, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an A.I. powered... ► Artikel lesen | |
| 28.07.25 | Hypha Labs, Inc.: Hypha Labs Provides Shareholder Update | 797 | ACCESS Newswire | LAS VEGAS, NEVADA / ACCESS Newswire / July 28, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls... ► Artikel lesen | |
| 10.06.25 | Hypha Labs, Inc.: Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence Techniques for Its Mushroom Accelerator | 500 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / June 10, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls suite... ► Artikel lesen | |
| 13.05.25 | Hypha Labs, Inc.: Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator | 416 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls suite of products, is pleased to announce... ► Artikel lesen | |
| 01.05.25 | Hypha Labs, Inc.: Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade | 625 | ACCESS Newswire | LAS VEGAS, NV / ACCESS Newswire / May 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls suite of products, is pleased to announce... ► Artikel lesen | |
| 09.04.25 | Hypha Labs, Inc.: New Mexico Governor Signs Bill Allowing for Psilocybin Use | 376 | ACCESS Newswire | 'Medical Psilocybin Act' Provides Legal Access to Citizens for the First Time LAS VEGAS, NV / ACCESS Newswire / April 9, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences... ► Artikel lesen | |
| 17.03.25 | Hypha Labs, Inc.: Hypha Laboratories Retains Stockhouse for International Awareness Campaign | 379 | ACCESS Newswire | Venerable, Popular Destination to Introduce Hypha Labs to Canadian and U.S. Investors LAS VEGAS, NV / ACCESS Newswire / March 17, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS | 21,200 | +65,75 % | Servier; Day One Biopharmaceuticals: Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio | Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with high unmet needs. Transaction represents... ► Artikel lesen | |
| QIAGEN | 39,095 | -3,59 % | Shortseller-Positionen aktuell: Auto1, Energiekontor, freenet, Gerresheimer, Puma, Qiagen, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| TANGO THERAPEUTICS | 16,950 | +0,77 % | Erasca, Inc.: Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat | ERAS-0015, a pan-RAS molecular glue, will be evaluated in combination with PRMT5 inhibitor vopimetostat Tango will sponsor the clinical trial and Erasca will supply ERAS-0015 at no cost SAN DIEGO... ► Artikel lesen | |
| IMMUNOME | 21,040 | +0,43 % | Immunome: Q4 Earnings Insights | ||
| KINIKSA PHARMACEUTICALS | 46,160 | +0,26 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution | - ARCALYST- (rilonacept) Q4 2025 and full year 2025 net product revenue of $202.1 million and $677.6 million, respectively -- ARCALYST 2026 net product revenue expected to be $900 - $920 million... ► Artikel lesen | |
| ARCELLX | 114,33 | -0,03 % | Arcellx stock rating cut to Hold by TD Cowen on Gilead deal | ||
| ARCUTIS BIOTHERAPEUTICS | 24,000 | +0,17 % | Arcutis Biotherapeutics, Inc.: Arcutis Announces Promotion of Mas Matsuda to Executive Vice President and Chief Legal Officer to Support Next Phase of Growth | WESTLAKE VILLAGE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen | |
| BIONTECH | 87,05 | -0,51 % | BioNTech-Konkurrent Moderna: Satter Kurssprung - jetzt noch einsteigen? | Die Aktie von Moderna hat zuletzt erneut kräftigen Rückenwind erhalten. Die Korrektur seit Ende Januar wurde damit nicht nur vollständig wieder ausgeglichen, das Papier konnte sogar auf ein neues Jahreshoch... ► Artikel lesen | |
| SOLID BIOSCIENCES | 6,750 | +20,43 % | Solid Biosciences Inc. - 8-K, Current Report | ||
| CG ONCOLOGY | 62,02 | +2,85 % | H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating | ||
| AMYLYX PHARMACEUTICALS | 13,850 | -1,77 % | Amylyx Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| APOGEE THERAPEUTICS | 73,08 | +2,99 % | RBC Capital lowers Apogee Therapeutics stock price target on dosing outlook | ||
| EVOTEC | 5,402 | -1,13 % | Shortseller-Positionen aktuell: Evotec, Gerresheimer, HelloFresh, Renk, Hypoport, Symrise, TUI | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| TAYSHA GENE THERAPIES | 4,570 | +1,78 % | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ||
| MODERNA | 45,130 | -0,29 % | Moderna freut sich über eine Zulassungsempfehlung der EMA für einen Kombi-Impfstoff gegen Corona und Grippe | Bei Corona-Impfstoffen war der US-Konzern Moderna noch ein Nachzügler. Anders scheint es nun bei Kombi-Impfstoffen zu laufen, die gleichzeitig vor Corona und der Grippe schützen. Dafür gibt es bisher... ► Artikel lesen |
HYPHA LABS INC gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HYPHA LABS INC finden Sie auf Wallstreet Online.